New report published by Global Info Research which offers insights on the global Prostate Cancer Treatment Drugs market.
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Click to view the full report TOC, figure and tables:
Global Prostate Cancer Treatment Drugs Market: Forecast by Type / Application / Region
The major players in global Cancer Treatment Drugs market include: Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, Astellas, Merck & Co., Sanofi, Bayer, Biogen Idec, Eisai, Teva, Otsuka, Merck KGaA, Ipsen, AbbVie, Gilead Sciences.
On the basis of products split into , Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy (Biologic Therapy), Others.
On the basis on the end users/applications covers: Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer, Other Cancers.
Global market of cancer treatment drugs developed rapidly, with an average growth rate of 7.56 In the last several years. In 2016, Global revenue of Cancer Treatment Drugs is nearly 117 billion USD.
The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.
Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.
Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.
North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion USD. China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.
Market competition is intense. Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Ask for Discount on Research Report and Request Sample Copy of Report@
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
United States Prostate Cancer Treatment Drugs Market 2018 Forecast to 2023
Europe Prostate Cancer Treatment Drugs Market 2018 Forecast to 2023
North America Prostate Cancer Treatment Drugs Market 2018 Forecast to 2023
Asia-Pacific Prostate Cancer Treatment Drugs Market 2018 Forecast to 2023
China Prostate Cancer Treatment Drugs Market 2018 Forecast to 2023
EMEA Prostate Cancer Treatment Drugs Market 2018 Forecast to 2023
Global Prostate Cancer Treatment Drugs Market 2018 Forecast to 2023
Contact US :
Sales Director (Global Info Research)
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong